NBRV · Categories · Form 4

NBRV - SEC Form 4 insider transactions

Nabriva Therapeutics plc (NBRV) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for NBRV

• 1226d
  SEC Form 4: Gelone Steven P. covered exercise/tax liability with 140 units of Ordinary Shares, decreasing direct ownership by 0.97% to 14,283 units to cover taxes

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1226d
  SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 431 units of Ordinary Shares, decreasing direct ownership by 3% to 11,989 units to satisfy tax liability

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1247d
  SEC Form 4: Gelone Steven P. covered exercise/tax liability with 5 units of Ordinary Shares, decreasing direct ownership by 0.03% to 14,423 units (for withholding tax)

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1247d
  SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 11 units of Ordinary Shares, decreasing direct ownership by 0.09% to 12,420 units to satisfy withholding obligation

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1253d
  SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 5 units of Ordinary Shares, decreasing direct ownership by 0.04% to 12,431 units (for tax liability)

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1253d
  SEC Form 4: Gelone Steven P. covered exercise/tax liability with 3 units of Ordinary Shares, decreasing direct ownership by 0.02% to 14,428 units (tax liability)

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1280d
  SEC Form 4: Gelone Steven P. covered exercise/tax liability with 4 units of Ordinary Shares, decreasing direct ownership by 0.03% to 14,431 units to cover taxes

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1280d
  SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 9 units of Ordinary Shares, decreasing direct ownership by 0.07% to 12,436 units (for tax liability)

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1286d
  SEC Form 4: Gelone Steven P. covered exercise/tax liability with 3 units of Ordinary Shares, decreasing direct ownership by 0.02% to 14,435 units (tax liability)

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1286d
  SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 5 units of Ordinary Shares, decreasing direct ownership by 0.04% to 12,445 units (tax liability)

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1310d
  SEC Form 4: Gelone Steven P. covered exercise/tax liability with 4 units of Ordinary Shares, decreasing direct ownership by 0.03% to 14,438 units to satisfy tax liability

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1310d
  SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 10 units of Ordinary Shares, decreasing direct ownership by 0.08% to 12,450 units (for withholding tax)

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1317d
  SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 5 units of Ordinary Shares, decreasing direct ownership by 0.04% to 12,460 units to cover taxes

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1317d
  SEC Form 4: Gelone Steven P. covered exercise/tax liability with 3 units of Ordinary Shares, decreasing direct ownership by 0.02% to 14,442 units to satisfy tax liability

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1338d
  SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 9 units of Ordinary Shares, decreasing direct ownership by 0.07% to 12,465 units to satisfy withholding tax

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1338d
  SEC Form 4: Gelone Steven P. covered exercise/tax liability with 4 units of Ordinary Shares, decreasing direct ownership by 0.03% to 14,445 units to satisfy withholding obligation

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1345d
  SEC Form 4: Gelone Steven P. covered exercise/tax liability with 3 units of Ordinary Shares, decreasing direct ownership by 0.02% to 14,449 units (withholding tax)

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1345d
  SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 5 units of Ordinary Shares, decreasing direct ownership by 0.04% to 12,474 units to cover taxes

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1372d
  SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 225 units of Ordinary Shares, decreasing direct ownership by 0.07% to 311,977 units (tax liability)

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1372d
  SEC Form 4: Gelone Steven P. covered exercise/tax liability with 89 units of Ordinary Shares, decreasing direct ownership by 0.02% to 361,311 units to cover withholding tax

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1378d
  SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 107 units of Ordinary Shares, decreasing direct ownership by 0.03% to 312,202 units (for withholding tax)

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1378d
  SEC Form 4: Gelone Steven P. covered exercise/tax liability with 61 units of Ordinary Shares, decreasing direct ownership by 0.02% to 361,400 units to satisfy withholding tax

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1395d
  SEC Form 4 filed by Schroeder Theodore R

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1395d
  SEC Form 4 filed by Gelone Steven P.

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1395d
  SEC Form 4 filed by Dolan Daniel

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1395d
  SEC Form 4 filed by Naftzger J. Christopher

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1395d
  SEC Form 4 filed by Guico-Pabia Christine J.

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1402d
  SEC Form 4: Gelone Steven P. covered exercise/tax liability with 89 units of Ordinary Shares, decreasing direct ownership by 0.02% to 361,461 units to cover withholding tax

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1402d
  SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 225 units of Ordinary Shares, decreasing direct ownership by 0.07% to 312,309 units to satisfy withholding obligation

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1406d
  SEC Form 4: Burgess Daniel D sold $2,156 worth of Ordinary Shares (11,341 units at $0.19), decreasing direct ownership by 52% to 10,384 units

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1406d
  SEC Form 4: Broom Colin Md sold $1,015 worth of Ordinary Shares (5,339 units at $0.19), decreasing direct ownership by 13% to 36,523 units

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1406d
  SEC Form 4: Webster Stephen W sold $1,487 worth of Ordinary Shares (7,826 units at $0.19), decreasing direct ownership by 41% to 11,447 units

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1406d
  SEC Form 4: Corrigan Mark sold $1,956 worth of Ordinary Shares (10,297 units at $0.19), decreasing direct ownership by 59% to 7,203 units

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1407d
  SEC Form 4: Rowland Charles A Jr sold $1,487 worth of Ordinary Shares (8,496 units at $0.17), decreasing direct ownership by 36% to 15,277 units

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1407d
  SEC Form 4: Bourdow Carrie L. sold $1,487 worth of Ordinary Shares (8,540 units at $0.17), decreasing direct ownership by 46% to 9,933 units

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1407d
  SEC Form 4: Dalton Lisa covered exercise/tax liability with 8,400 units of Ordinary Shares, decreasing direct ownership by 48% to 9,100 units to cover taxes

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1407d
  SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 107 units of Ordinary Shares, decreasing direct ownership by 0.03% to 312,534 units (for tax liability)

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1407d
  SEC Form 4: Gelone Steven P. covered exercise/tax liability with 61 units of Ordinary Shares, decreasing direct ownership by 0.02% to 361,550 units to cover taxes

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1434d
  SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 225 units of Ordinary Shares, decreasing direct ownership by 0.07% to 312,641 units (withholding obligation)

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1434d
  SEC Form 4: Gelone Steven P. covered exercise/tax liability with 89 units of Ordinary Shares, decreasing direct ownership by 0.02% to 361,611 units to satisfy tax liability

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1440d
  SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 107 units of Ordinary Shares, decreasing direct ownership by 0.03% to 312,866 units to satisfy withholding tax

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1440d
  SEC Form 4: Gelone Steven P. covered exercise/tax liability with 61 units of Ordinary Shares, decreasing direct ownership by 0.02% to 361,700 units (for tax liability)

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1464d
  SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 225 units of Ordinary Shares, decreasing direct ownership by 0.07% to 312,973 units (withholding tax)

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1464d
  SEC Form 4: Gelone Steven P. covered exercise/tax liability with 89 units of Ordinary Shares, decreasing direct ownership by 0.02% to 361,761 units to cover taxes

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1469d
  SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 107 units of Ordinary Shares, decreasing direct ownership by 0.03% to 313,198 units to satisfy withholding tax

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1469d
  SEC Form 4: Gelone Steven P. covered exercise/tax liability with 61 units of Ordinary Shares, decreasing direct ownership by 0.02% to 361,850 units to cover withholding tax

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1493d
  SEC Form 4: Gelone Steven P. covered exercise/tax liability with 89 units of Ordinary Shares, decreasing direct ownership by 0.02% to 361,911 units to cover withholding tax

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1493d
  SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 225 units of Ordinary Shares, decreasing direct ownership by 0.07% to 313,305 units (for tax liability)

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1499d
  SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 107 units of Ordinary Shares, decreasing direct ownership by 0.03% to 313,530 units (withholding obligation)

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1499d
  SEC Form 4: Gelone Steven P. covered exercise/tax liability with 61 units of Ordinary Shares, decreasing direct ownership by 0.02% to 362,000 units (tax withholding)

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1524d
  SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 219 units of Ordinary Shares, decreasing direct ownership by 0.07% to 313,637 units (for tax liability)

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1524d
  SEC Form 4: Gelone Steven P. covered exercise/tax liability with 89 units of Ordinary Shares, decreasing direct ownership by 0.02% to 362,061 units to cover taxes

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1528d
  SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 104 units of Ordinary Shares, decreasing direct ownership by 0.03% to 313,856 units (tax withholding)

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1528d
  SEC Form 4: Gelone Steven P. covered exercise/tax liability with 61 units of Ordinary Shares, decreasing direct ownership by 0.02% to 362,150 units (withholding obligation)

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1555d
  SEC Form 4: Gelone Steven P. covered exercise/tax liability with 89 units of Ordinary Shares, decreasing direct ownership by 0.02% to 362,211 units (withholding tax)

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1555d
  SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 263 units of Ordinary Shares, decreasing direct ownership by 0.08% to 313,960 units to satisfy tax liability

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1561d
  SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 125 units of Ordinary Shares, decreasing direct ownership by 0.04% to 314,223 units to satisfy withholding obligation

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1561d
  SEC Form 4: Gelone Steven P. covered exercise/tax liability with 61 units of Ordinary Shares, decreasing direct ownership by 0.02% to 362,300 units to satisfy withholding obligation

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1583d
  SEC Form 4: Gelone Steven P. covered exercise/tax liability with 106 units of Ordinary Shares, decreasing direct ownership by 0.03% to 362,361 units to satisfy withholding obligation

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)
• 1583d
  SEC Form 4: Schroeder Theodore R covered exercise/tax liability with 263 units of Ordinary Shares, decreasing direct ownership by 0.08% to 314,348 units to cover withholding tax

  4 - Nabriva Therapeutics plc (0001641640) (Issuer)

Other NBRV categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends